Miracle Touch Up

Why This Skinbooster Is Different

Mechanism of Action

Specifications

Product Name	Miracle Touch Up
Category	PCL Collagen Stimulator
Active Ingredients	Polycaprolactone (PCL) microspheres, Hyaluronic Acid (sodium salt), Pyroglutamic Acid, Polyethylene glycol carrier
Mechanism Class	PCL biostimulator (biodegradable polymer collagen induction)
Manufacturer	Dexrevo (Korea)
Origin	South Korea
Pack	5 × 2 mL vials per box
Lidocaine	Not included
Injection Technique	Multi-point intradermal or linear retrograde subdermal. Gentle massage post-injection.
Injection Depth	Intradermal to subdermal
Recommended Needle	27–30G; mesotherapy multi-point or linear retrograde
Treatment Protocol	3 sessions, 4 weeks apart. Effects build over 6–8 weeks as PCL-induced collagen response matures.
Effect Duration	Effect duration up to ~12 months reported
Storage	2–25 °C, protect from light and freezing.
Shelf Life	24 months unopened
Regulatory	Korean-manufactured PCL-based skin booster. PCL is an FDA-approved biodegradable polymer in other product categories (sutures, biostimulator fillers). Verify CE / KFDA status of the specific batch for this product.
SKU	FF-SB-MIRACLE-TOUCHUP

Clinical Indications

Compare Within Skinbooster Category

@media(max-width:640px){.swipe-hint{display:block !important}}

Frequently Asked Questions

What is PCL and how does it work in the skin?

PCL stands for polycaprolactone — a biodegradable synthetic polymer. The PCL microspheres trigger a controlled foreign-body response: macrophages encapsulate the microspheres, fibroblasts are recruited, and new collagen is deposited around the microspheres over weeks. As the PCL slowly degrades (over months), the new collagen remains — that is the source of the sustained effect.

How is Touch Up different from a PCL dermal filler (Ellanse)?

Both use PCL but at very different concentrations and placement. Ellanse is a dermal filler — high PCL concentration, placed in the subcutaneous or deep dermal layer for structural volume correction. Touch Up is a booster — lower PCL load, placed in the dermal plane via multi-point microinjection for diffuse skin tightening. Different objective, different injection technique.

How is Touch Up different from PLLA (Sculptra)?

Both PCL and PLLA are biodegradable polymers that trigger collagen induction. PCL degrades more slowly than PLLA, giving a longer in-situ residence — published durations of up to 24 months for PCL fillers vs ~24 months for PLLA. For Touch Up's booster application, the effect duration is ~12 months. Selection between PCL and PLLA is at practitioner discretion.

Is it reversible if there's a complication?

No. Unlike HA-based products (which can be dissolved with hyaluronidase), PCL is not reversible — once injected, the body's response cannot be reversed pharmacologically. This is a key clinical consideration. The trade-off is longer-lasting effect with less correction flexibility.

How many sessions are needed?

The standard protocol is three sessions, four weeks apart. Effects build over 6–8 weeks after each session as the collagen response matures. Patients typically reach peak benefit 12–16 weeks after the third session, with effects sustained up to ~12 months from the completed course.

Is it suitable for patients with HA fatigue or HA hypersensitivity?

Yes — this is one of the most clinically relevant indications. Patients who cannot tolerate HA (true hypersensitivity, delayed-onset nodules) or who have reached HA-fatigue (diminished response after repeated HA filler) benefit from a non-HA biostimulator route. Touch Up provides that pathway.

What injection technique is used?

Multi-point intradermal placement is most common: 0.05–0.1 mL per point at ~1 cm spacing. Linear retrograde subdermal technique can be used for larger areas. Gentle post-injection massage helps distribute the PCL evenly through the field. Patient repositioning and immediate post-injection assessment are essential.

Does it produce immediate volume effect?

No — and patients should be counselled accordingly. Unlike HA fillers, PCL-based products produce no immediate volume change. The visible benefit is delayed, building over 6–8 weeks as the collagen response matures. This is important for managing patient expectations.

Are there contraindications?

Standard injectable contraindications apply: pregnancy and lactation, active infection at the treatment site, severe coagulopathy, hypersensitivity to PCL or HA, history of keloid formation. Patients with a history of granulomatous reactions to dermal fillers should not receive PCL-based products.

What downtime should patients expect?

Mild swelling, redness, and small papules at injection points are normal and resolve within 24–72 hours. Bruising may occur and typically resolves within a week. Patients can usually return to social activity the day after treatment. Heat exposure (sauna, sun) should be avoided for 48 hours.

Source verification: → FDA 510(k) Database (verification)

Related Skin Boosters

Regulatory Notice. Korean-manufactured PCL-based skin booster. PCL is an FDA-approved biodegradable polymer in other product categories (sutures, biostimulator fillers). Verify CE / KFDA status of the specific batch for this product. This product is manufactured outside the United States; FDA approval status is product-specific. For licensed healthcare professionals only. Practitioners are responsible for verifying regulatory status of this product in their jurisdiction before clinical use. Not for retail sale. Pricing subject to change.